Literature DB >> 18325721

Effects of recombinant bovine somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows.

Robert J Collier1, M A Miller, C L McLaughlin, H D Johnson, C A Baile.   

Abstract

During two studies, effects of recombinant bovine somatotropin (rbST) on plasma and milk IGF's in cows adapted to summer (S; 12 cows) or winter (W; 12 cows) conditions were evaluated. Each study consisted of on-farm periods (30 days) followed by climatology chamber periods (CC; 30 days). Cows were given daily injections of rbST, Sometribove, USAN (25mg/day; 6 cows each study) or saline (control; 6 cows each study). During on-farm periods, blood and milk (am and pm) samples were collected once weekly. During CC periods, blood samples were collected every 2 days and milk samples (am and pm) were collected daily. Plasma IGF-I and IGF-II were increased in cows treated with rbST. A pronounced seasonal pattern in basal and rbST-stimulated plasma IGF-I but not IGF-II was detected. Higher basal and rbST-stimulated plasma IGF-I concentrations in S occurred despite large decreases in feed intake and energy balance. Milk IGF-I and IGF-II was not affected by rbST treatment or season. Although milk IGF-I and IGF-II concentrations were unaffected by rbST treatment, total IGF-output increased due to increased milk yield. The observed seasonal patterns in plasma IGF-I may be indicative of seasonal differences in the coupling of the somatotropin-IGF axis. In particular, we failed to detect an uncoupling of the somatotropin-IGF-I axis in S despite an induced negative energy balance during thermal stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325721     DOI: 10.1016/j.domaniend.2008.01.003

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  8 in total

1.  Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats.

Authors:  Tina S Nielsen; Galam Khan; Jennifer Davis; Karin B Michels; Leena Hilakivi-Clarke
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

2.  Effects of an evaporative cooling system on plasma cortisol, IGF-I, and milk production in dairy cows in a tropical environment.

Authors:  Cristiane Gonçalves Titto; João Alberto Negrão; Evaldo Antonio Lencioni Titto; Taissa de Souza Canaes; Rafael Martins Titto; Alfredo Manuel Franco Pereira
Journal:  Int J Biometeorol       Date:  2012-05-14       Impact factor: 3.787

Review 3.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

4.  [Acne vulgaris. Role of diet].

Authors:  B Melnik
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

Review 5.  Pharmacological overview of galactogogues.

Authors:  Felipe Penagos Tabares; Juliana V Bedoya Jaramillo; Zulma Tatiana Ruiz-Cortés
Journal:  Vet Med Int       Date:  2014-08-31

6.  Effect of two formulations of recombinant bovine somatotropin on milk production and body condition of cattle under intensive management in Peru.

Authors:  Carlos A Gómez; Melisa Fernández; Néstor Franco; Rudi Cueva
Journal:  Trop Anim Health Prod       Date:  2022-02-09       Impact factor: 1.559

7.  Intake of dairy products, calcium, magnesium, and phosphorus in childhood and age at menarche in the Tehran Lipid and Glucose Study.

Authors:  Fahimeh Ramezani Tehrani; Nazanin Moslehi; Golaleh Asghari; Roya Gholami; Parvin Mirmiran; Fereidoun Azizi
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

8.  Consumption of Dairy Products and the Risk of Developing Breast Cancer in Polish Women.

Authors:  Bożena Wajszczyk; Jadwiga Charzewska; Dariusz Godlewski; Brunon Zemła; Elżbieta Nowakowska; Maciej Kozaczka; Małgorzata Chilimoniuk; Dorothy R Pathak
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.